These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6250682)

  • 1. Is THC an effective antiemetic for cancer patients? Opinion 2.
    Sallan SE; Cronin CM
    CA Cancer J Clin; 1980; 30(5):283-5. PubMed ID: 6250682
    [No Abstract]   [Full Text] [Related]  

  • 2. Is THC an effective antiemetic for cancer patients? Opinion 1.
    Frytak S
    CA Cancer J Clin; 1980; 30(5):278-82. PubMed ID: 6250681
    [No Abstract]   [Full Text] [Related]  

  • 3. delta 9-tetrahydrocannabinol in clinical oncology.
    Poster DS; Penta JS; Bruno S; Macdonald JS
    JAMA; 1981 May 22-29; 245(20):2047-51. PubMed ID: 6262541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis and cancer chemotherapy.
    Bedell SE
    Ann Intern Med; 1979 Feb; 90(2):276. PubMed ID: 443672
    [No Abstract]   [Full Text] [Related]  

  • 5. delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy.
    Lucas VS; Laszlo J
    JAMA; 1980 Mar; 243(12):1241-3. PubMed ID: 6244418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy.
    Einhorn L
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():55-61. PubMed ID: 6299557
    [No Abstract]   [Full Text] [Related]  

  • 7. Dronabinol and nabilone ease cancer chemotherapy.
    Manzo M
    Nursing; 1988 Aug; 18(8):81. PubMed ID: 2839807
    [No Abstract]   [Full Text] [Related]  

  • 8. Dronabinol Therapy: Central Nervous System Adverse Events in Adults With Primary Brain Tumors.
    Allen D
    Clin J Oncol Nurs; 2019 Feb; 23(1):23-26. PubMed ID: 30681988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta-9-tetrahydrocannabinol in cancer chemotherapy: research problems and issues.
    Carey MP; Burish TG; Brenner DE
    Ann Intern Med; 1983 Jul; 99(1):106-14. PubMed ID: 6305249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials with antiemetic agents in cancer patients receiving chemotherapy.
    Penta JS; Poster DS; Bruno S; Macdonald JS
    J Clin Pharmacol; 1981; 21(S1):11S-22S. PubMed ID: 6271815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.
    Orr LE; McKernan JF; Bloome B
    Arch Intern Med; 1980 Nov; 140(11):1431-3. PubMed ID: 6254456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. delta 9-Tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A pilot study.
    Sweet DL; Miller NJ; Weddington W; Senay E; Sushelsky L
    J Clin Pharmacol; 1981; 21(S1):70S-75S. PubMed ID: 6271845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress inoculation training in the control of THC toxicities.
    Roffman RA
    Int J Addict; 1986 Aug; 21(8):883-96. PubMed ID: 3021638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative trial of the antiemetic effects of THC and haloperidol.
    Neidhart JA; Gagen MM; Wilson HE; Young DC
    J Clin Pharmacol; 1981; 21(S1):38S-42S. PubMed ID: 6271838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Many cancer patients receiving THC as antiemetic.
    Gunby P
    JAMA; 1981 Apr; 245(15):1515, 1518. PubMed ID: 6259381
    [No Abstract]   [Full Text] [Related]  

  • 16. Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting.
    Lane M; Vogel CL; Ferguson J; Krasnow S; Saiers JL; Hamm J; Salva K; Wiernik PH; Holroyde CP; Hammill S
    J Pain Symptom Manage; 1991 Aug; 6(6):352-9. PubMed ID: 1652611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine.
    Orr LE; McKernan JF
    J Clin Pharmacol; 1981; 21(S1):76S-80S. PubMed ID: 6271846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy.
    McCabe M; Smith FP; Macdonald JS; Woolley PV; Goldberg D; Schein PS
    Invest New Drugs; 1988 Sep; 6(3):243-6. PubMed ID: 2847994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The California program for the investigational use of THC and marihuana in heterogeneous populations experiencing nausea and vomiting from anticancer therapy.
    Dow GJ; Meyers FH
    J Clin Pharmacol; 1981; 21(S1):128S-132S. PubMed ID: 6271818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic treatment of chemotherapy-induced nausea and vomiting.
    Fiore JJ; Gralla RJ
    Cancer Invest; 1984; 2(5):351-61. PubMed ID: 6093949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.